Suppr超能文献

大型动脉导管未闭合并重度肺动脉高压的治疗。

Treatment of severe pulmonary hypertension in the setting of the large patent ductus arteriosus.

机构信息

Lillie Frank Abercrombie Section of Pediatric Cardiology, Texas Children’s Hospital, Houston, Texas, USA.

出版信息

Pediatrics. 2013 May;131(5):e1643-9. doi: 10.1542/peds.2011-1417. Epub 2013 Apr 29.

Abstract

Treatment of the large patent ductus arteriosus (PDA) in the setting of pulmonary hypertension (PH) is challenging. Left patent, the large PDA can result in irreversible pulmonary vascular disease. Occlusion, however, may lead to right ventricular failure for certain patients with severe PH. Our center has adopted a staged management strategy using medical management, noninvasive imaging, and invasive cardiac catheterization to treat PH in the presence of a large PDA. This approach determines the safety of ductal closure but also leverages medical therapy to create an opportunity for safe PDA occlusion. We reviewed our experience with this approach. Patients with both severe PH and PDAs were studied. PH treatment history and hemodynamic data obtained during catheterizations were reviewed. Repeat catheterizations, echocardiograms, and clinical status at latest follow-up were also reviewed. Seven patients had both PH and large, unrestrictive PDAs. At baseline, all patients had near-systemic right ventricular pressures. Nine catheterizations were performed. Two patients underwent 2 catheterizations each due to poor initial response to balloon test occlusion. Six of 7 patients exhibited subsystemic pulmonary pressures during test occlusion and underwent successful PDA occlusion. One patient did not undergo PDA occlusion. In follow-up, 2 additional catheterizations were performed after successful PDA occlusion for subsequent hemodynamic assessment. At the latest follow-up, the 6 patients who underwent PDA occlusion are well, with continued improvement in PH. Five patients remain on PH treatment. A staged approach to PDA closure for patients with severe PH is an effective treatment paradigm. Aggressive treatment of PH creates a window of opportunity for PDA occlusion, echocardiography assists in identifying the timing for closure, and balloon test occlusion during cardiac catheterization is critical in determining safety of closure. By safely eliminating the large PDA, this treatment algorithm can halt the perilous combination of the large shunting from the PDA and PH in a population at high risk of morbidity and mortality.

摘要

治疗肺动脉高压 (PH) 合并大型动脉导管未闭 (PDA) 具有挑战性。左向右分流的大型 PDA 可导致不可逆转的肺血管疾病。然而,对于某些严重 PH 的患者,PDA 闭塞可能导致右心室衰竭。我们中心采用了一种分阶段管理策略,使用药物治疗、非侵入性影像学和有创性心导管检查来治疗存在大型 PDA 的 PH。这种方法确定了导管闭合的安全性,但也利用药物治疗为安全闭合 PDA 创造了机会。我们回顾了这种方法的经验。研究了同时患有严重 PH 和 PDA 的患者。回顾了导管检查期间获得的 PH 治疗史和血流动力学数据。还回顾了重复的导管检查、超声心动图和最新随访时的临床状况。7 例患者同时患有 PH 和大型非限制性 PDA。在基线时,所有患者的右心室压力接近系统性。共进行了 9 次导管检查。由于对球囊测试闭塞的初始反应不佳,2 例患者各进行了 2 次导管检查。6/7 例患者在测试闭塞期间出现亚系统性肺压,并成功进行了 PDA 闭塞。1 例患者未进行 PDA 闭塞。在后续治疗中,在成功进行 PDA 闭塞后进行了另外 2 次导管检查,以进行随后的血流动力学评估。在最新的随访中,6 例成功进行 PDA 闭塞的患者情况良好,PH 持续改善。5 例患者仍在接受 PH 治疗。对于严重 PH 的患者,分阶段的 PDA 闭合方法是一种有效的治疗模式。积极治疗 PH 为 PDA 闭合创造了机会窗口,超声心动图有助于确定闭合时机,而心导管检查中的球囊测试闭塞对于确定闭合的安全性至关重要。通过安全消除大型 PDA,这种治疗算法可以阻止在高发病率和死亡率风险人群中,大型 PDA 分流和 PH 之间的危险组合。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验